Table 1.

Patient characteristics (n= 66,636)

Age (years)	54±11
Male (n, %)	44,633 (67)
White/Black/Hispanic/Others (%)	89/2/3/6
BMI (kg/m2)	27.5±5.3
Hypertension (n, %)	20,624 (31)
Diabetes (n, %)	4,503 (7)
Hyperlipidemia (n, %)	36,227 (54)
Current smoking (n, %)	6,400 (10)
Family history of CHD (n, %)	30,720 (46)
ASCVD risk score (mean ± SD)	7.4 ± 8.9%
CAC score (n, %) (n=66,636)
CAC 0	29,757 (45)
CAC 1–99	20,534 (30)
CAC 100–399	7,341 (14)
CAC ≥400	9,004 (11)
TAC score (n, %) (n=41,066)
TAC 0	19,476 (48)
TAC 1–99	11,927 (29)
TAC 100–399	5,415 (13)
TAC ≥400	4,248 (10)
AVC score (n, %) (n=10,007)
AVC 0	8,610 (86)
AVC 1–99	876 (9)
AVC 100–399	352 (3)
AVC ≥400	169 (2)
MVC score (n, %) (n=10,008)
MVC 0	9,416 (94)
MVC 1–99	283 (3)
MVC 100–399	150 (1)
MVC ≥400	159 (2)

Abbreviations: BMI- Body mass index, CHD- Coronary heart disease, ASCVD- Atherosclerotic cardiovascular disease, CAC- Coronary artery calcium, TAC- Thoracic aortic calcification, AVC- Aortic valve calcification, MVC- Mitral valve calcification